AMGEN GmbH Firmenkenndaten im Überblick

Product Range

Prevention of skeletal related events/complications in case of tumors, Bone loss due to anti-hormonal therapy, Side effects of chemotherapies on the production of red and white blood cells, Colorectal cancer, Primary Immune Thrombocytopenia (ITP), Primary and secondary hyperparathyroidism, Anemia in chronic kidney failure, Postmenopausal osteoporosis, Lipid metabolism disorder

Key Research Areas AMGEN GmbH

Oncology /Hematology, Inflammation, Metabolic Disorders, Neuroscience, Nephrology, Cardiology
(All data based on corporate information from member AMGEN GmbH , as of: 08/2017)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download